Pemphigus group: overview, epidemiology, mortality, and comorbidities
- PMID: 29479654
- DOI: 10.1007/s12026-018-8986-7
Pemphigus group: overview, epidemiology, mortality, and comorbidities
Abstract
Pemphigus forms a group of rare autoimmune bullous diseases that affect the skin and mucous membranes. This group has a chronic course leading to high morbidity and mortality. It is characterized by the production of pathogenic autoantibodies directed against different proteins of the desmosome, leading histologically to intraepidermal cleavage, and clinically to vesicles and erosions on the epithelium of the mucous membranes and/or the skin. The diagnosis of the subtype of pemphigus is based on clinical features, the level of histologic cleavage, and the identification of the antigens recognized by circulating autoantibodies by immunoserological analyses. The epidemiological features of pemphigus vary considerably in different regions of the world. Observational studies examining comorbidities and associations among patients with pemphigus are scarce and sometimes inconclusive. The prognosis, mortality, and clinical outcomes in pemphigus have undergone dramatic change throughout the years. This review provides a brief overview about the different subtypes of pemphigus: pemphigus vulgaris, pemphigus foliaceus, paraneoplastic pemphigus, pemphigus herpetiformis, and IgA pemphigus. In addition, it summarizes the most recent understanding of the epidemiology, mortality data, and comorbidities of this group of organ-specific autoimmune diseases.
Keywords: Associations; Comorbidities; Epidemiology; IgA pemphigus; Mortality; Paraneoplastic pemphigus; Pemphigus; Pemphigus foliaceus; Pemphigus herpetiformis; Pemphigus vulgaris.
Similar articles
-
Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis).Clin Dermatol. 2011 Jul-Aug;29(4):432-6. doi: 10.1016/j.clindermatol.2011.01.013. Clin Dermatol. 2011. PMID: 21679871
-
[Pemphigus].Rev Prat. 1994 Jan 1;44(1):81-5. Rev Prat. 1994. PMID: 8178064 French.
-
The new pemphigus variants.J Am Acad Dermatol. 1999 May;40(5 Pt 1):649-71; quiz 672-3. doi: 10.1016/s0190-9622(99)70145-3. J Am Acad Dermatol. 1999. PMID: 10321591 Review.
-
Diagnosis and clinical features of pemphigus vulgaris.Immunol Allergy Clin North Am. 2012 May;32(2):233-43, v-vi. doi: 10.1016/j.iac.2012.04.003. Immunol Allergy Clin North Am. 2012. PMID: 22560136 Review.
-
Diagnosis and classification of pemphigus and bullous pemphigoid.Autoimmun Rev. 2014 Apr-May;13(4-5):477-81. doi: 10.1016/j.autrev.2014.01.011. Epub 2014 Jan 11. Autoimmun Rev. 2014. PMID: 24424192 Review.
Cited by
-
Human dental mesenchymal stem cells restorate immune response in sera of pemphigus vulgaris patients.Arch Dermatol Res. 2024 Oct 1;316(9):655. doi: 10.1007/s00403-024-03358-6. Arch Dermatol Res. 2024. PMID: 39352524
-
A Comprehensive Review on the Intricate Interplay between COVID-19 Immunization and the New Onset of Pemphigus Foliaceus.Vaccines (Basel). 2024 Jul 30;12(8):857. doi: 10.3390/vaccines12080857. Vaccines (Basel). 2024. PMID: 39203983 Free PMC article. Review.
-
Epidemiological Insights into Autoimmune Bullous Diseases in China: A Comprehensive Analysis.J Epidemiol Glob Health. 2024 Sep;14(3):513-523. doi: 10.1007/s44197-024-00277-7. Epub 2024 Jul 22. J Epidemiol Glob Health. 2024. PMID: 39037699 Free PMC article.
-
A case of IgA pemphigus, with a poor response to dapsone, successfully treated with adalimumab.Clin Case Rep. 2024 May 14;12(5):e8807. doi: 10.1002/ccr3.8807. eCollection 2024 May. Clin Case Rep. 2024. PMID: 38751960 Free PMC article.
-
The evolution of Pemphigus publications: A bibliometric analysis with research trends and global productivity.Medicine (Baltimore). 2024 May 3;103(18):e38047. doi: 10.1097/MD.0000000000038047. Medicine (Baltimore). 2024. PMID: 38701303 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
